ASCEND
BY NTHRYS

NTHRYS › PhD Assistance › Pharmacogenetics

Pharmacogenetics

Field
▾
Category
▾

Pharmacogenetics

Select a category to explore research frontiers

Loading categories...

Research Frontiers in Clopidogrel Responsiveness and CYP2C19 Loss-of-Function

Assessment of CYP2C19 polymorphisms determining clopidogrel activation and predicting cardiovascular outcomes in antiplatelet therapy.

CYP2C19 Loss-of-Function Polymorphisms in Antiplatelet Resistance
Genetic Stratification of Clopidogrel Bioactivation and Clinical Outcomes
Epistatic Interactions Between CYP2C19 and Platelet P2Y12 Signaling
Metabolic Phenotyping Beyond CYP2C19 in Thienopyridine Response
Ethnicity-Dependent CYP2C19 Variants and Personalized Antiplatelet Dosing
Sequential Bioconversion Failures in Clopidogrel Pharmacokinetics
CYP2C19 Polymorphisms as Modifiers of Stent Thrombosis Risk
Alternative Metabolic Pathways Compensating for CYP2C19 Deficiency
Dynamic CYP2C19 Expression Changes During Acute Coronary Syndrome
Pharmacogenetic Signatures Predicting Clopidogrel-to-Prasugrel Treatment Switching

All Pharmacogenetics PhD categories